SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 24 May · 16:13 IST

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shilpa Medicare Limited has submitted a disclosure to the stock exchanges under Regulation 30 of the SEBI Listing Regulations. Regulation 30 requires listed companies to inform exchanges about material events or information that could affect investors' decisions. No further details about the specific event being disclosed were provided in the filing content shared.

Likely market impact

Without the actual details of the intimation, the specific impact on shareholders or the stock cannot be assessed. Investors should check the full filing on the NSE/BSE website to understand what material information was disclosed.